PARP1 and Alzheimer disease: In comparing the distinct PARP-1 subgroup, we found a significantly lower percentage of nucleoli staining in MCI and AD cases compared to Control (Figure 1(c), Black Bars in Left Panel; MANOVA: F2,13 = 5.810 p = .002.